DrugPatentWatch Database Preview
ENBREL Drug Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Summary for Tradename: ENBREL
| Patents: | 338 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 2 |
| Drug Prices: | Drug price information for ENBREL |
| Recent Clinical Trials: | See clinical trials for ENBREL |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ENBREL |
Recent Clinical Trials for ENBREL
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Lawson Health Research Institute | Phase 4 |
| Academic Medical Organization of Southwestern Ontario | Phase 4 |
| LEO Pharma | Phase 4 |
Recent Litigation for ENBREL
Identify key patents and potential future biosimilar entrants
District Court Litigation
| Case Name | Date |
|---|---|
| CELGENE CORPORATION v. MYLAN PHARMACEUTICALS INC. | 2019-12-31 |
| CELGENE CORPORATION v. HETERO LABS LIMITED | 2019-07-16 |
| CELGENE CORPORATION v. DR. REDDY'S LABORATORIES, LTD. | 2019-07-12 |
PTAB Litigation
| Petitioner | Date |
|---|---|
| Dr. Reddy's Laboratories, Inc. | 2018-08-03 |
Pharmacology for ENBREL
| Mechanism of Action | Tumor Necrosis Factor Receptor Blocking Activity |
Company Disclosures: US Patents for ENBREL
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | Start Trial | Immunex Corporation (Seattle, WA) | 2012-03-07 | RX | Orphan | company |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | Start Trial | Immunex Corporation (Seattle, WA) | 2014-02-25 | RX | Orphan | company |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | Start Trial | Immunex Corporation (Seattle, WA) | 2009-09-05 | RX | Orphan | company |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | Start Trial | Immunex Corporation (Seattle, WA) | 2009-09-11 | RX | Orphan | company |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | Start Trial | 2009-09-05 | RX | Orphan | company | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Patent Text Search: US Patents for ENBREL
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | Start Trial | Massachusetts Eye and Ear Infirmary (Boston, MA) | 2034-06-16 | RX | Orphan | search |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | Orphan | search |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | Start Trial | Knopp Biosciences LLC (Pittsburgh, PA) | 2033-08-13 | RX | Orphan | search |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | Start Trial | Coherus Biosciences, Inc. (Redwood City, CA) | 2039-02-26 | RX | Orphan | search |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | Start Trial | LUPIN LIMITED (Mumbai, Maharashtra, IN) | 2032-10-26 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for ENBREL
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Hungary | 0402162 | Start Trial |
| Mexico | 2015006900 | Start Trial |
| Spain | 2543735 | Start Trial |
| Australia | 2011218756 | Start Trial |
| Japan | 6195611 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for ENBREL
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 273 5026-2016 | Slovakia | Start Trial | PRODUCT NAME: IBRUTINIB VO VSETKYCH FORMACH CHRANENYCH ZA- KLADNYM PATENTOM; REGISTRATION NO/DATE: EU/1/14/945 20160530 |
| LUC00011 | Luxembourg | Start Trial | PRODUCT NAME: IBRUTINIB, OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/14/945 20150707 |
| C300728 | Netherlands | Start Trial | PRODUCT NAME: IBRUTINIB OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT ERVAN; REGISTRATION NO/DATE: EU/1/14/945 20141021 |
| LUC00125 | Luxembourg | Start Trial | PRODUCT NAME: APREMILAST, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; AUTHORISATION NUMBER AND DATE: |
| C20170010 00272 | Estonia | Start Trial | PRODUCT NAME: IBRUTINIIB;REG NO/DATE: EU/1/14/945 23.10.2014 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
